ARRB2 and medulloblastoma: The study by Kallifatidis et al. verifies that ARRB2 is involved in leukemia and medulloblastoma and combines with other molecular compounds [30], indicating that it can regulate the characteristics of stem cells and might be used as a potential target in tumor treatment.